Form 8-K - Current report:
SEC Accession No. 0001213900-25-057831
Filing Date
2025-06-25
Accepted
2025-06-25 16:30:11
Documents
14
Period of Report
2025-06-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0246968-8k_aditxt.htm   iXBRL 8-K 42785
2 FORM OF WARRANT ea024696801ex4-1_aditxt.htm EX-4.1 60403
3 FORM OF UNSECURED PROMISSORY NOTE DATED JUNE 20, 2025 ea024696801ex10-1_aditxt.htm EX-10.1 18918
  Complete submission text file 0001213900-25-057831.txt   310613

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE adtx-20250620.xsd EX-101.SCH 3008
5 XBRL LABEL FILE adtx-20250620_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE adtx-20250620_pre.xml EX-101.PRE 22354
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0246968-8k_aditxt_htm.xml XML 3792
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

EIN.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39336 | Film No.: 251073975
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)